The Gaithersburg biotechnology company, Novavax, announced Monday morning data from phase 3 of its COVID-19 vaccine trials which were conducted in the United States and Mexico. Novavax found that the trial, which began in December and enrolled 29,960 participants, had an overall efficacy rate of 90.04%. Last year, Novavax was awarded $1.6 billion from the […]
Novavax Expected to Make Announcement About Data from Vaccine Trials Soon
Novavax CEO Stan Erck said that the company will likely make an announcement about data from phase 3 of its COVID-19 vaccine trials as soon as next week. “I’m happy to say that the data are coming very soon, in fact, we hope to announce those data next week,” Erck said. The comments were made […]
Hogan Recorre Futura Sede de Novavax en Gaithersburg; Ofrecerán 500 Empleos Adicionales
El gobernador Larry Hogan y otros líderes visitaron Gaithersburg el jueves para recorrer el sitio de la futura sede mundial de Novavax. Hace más de un año, Novavax comenzó a desarrollar una vacuna COVID-19. Stan Erck, presidente y director ejecutivo de Novavax, dijo que Novavax está completando la fase tres de los ensayos de vacunas […]
Hogan Tours Future Site of Novavax Global HQ in Gaithersburg; 500 Jobs to be Added
Gov. Larry Hogan and other leaders visited Gaithersburg on Thursday to tour the site of Novavax’s future global headquarters. More than a year ago, Novavax began developing a promising COVID-19 vaccine. Stan Erck, the president and CEO of Novavax, said that Novavax is completing phase three of vaccine trials and results have been promising. “I’m happy to […]
Hogan to Tour Site of Future Novavax Campus, Global Headquarters in Gaithersburg
Gov. Larry Hogan is heading to Gaithersburg on Thursday to tour the site of Novavax’s future 180,000 square foot Vaccine Innovation Campus and Global Headquarters. This comes after the Gaithersburg City Council unanimously approved a sketch plan for the new facility, which will be located at 14 Firstfield Road, on Monday. Hogan will be joined […]
Novavax to Provide 1.1 Billion COVID-19 Vaccine Doses Globally
Novavax, a vaccine development company headquartered in Gaithersburg, announced Thursday that it entered into a Memorandum of Understanding (MOU) with an international vaccine organization to provide more than 1 billion total doses of Novavax’s COVID-19 vaccine candidate, according to a statement from the company. Novavax will work with Gavi, the Vaccine Alliance to provide 1.1 […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia